Nazik Hammad has joined The Institute of Cancer and Crisis board of directors
The Institute of Cancer and Crisis (ICC) shared a post on LinkedIn:
“Exciting News!
We are thrilled to announce that Nazik Hammad has joined The Institute of Cancer and Crisis (ICC) board of directors!
ICC greatly values the effort and support provided by all our esteemed members, and we believe that this collaboration with Dr. Hammad will bring numerous benefits.
Nazik Hammad is a Sudanese Canadian Professor of medical oncology, at Saint Michael Hospital, Department of Medicine, University of Toronto . Her academic work and research interests include medical education and workforce development in low and middle-income countries (LMIC) particularly in sub-Saharan Africa. Other research and academic interests include value-based cancer care, global and local inequities and disparities in cancer, global health and global oncology, women as health care professionals and cancer in conflict zones. Together with colleagues in Africa she led the first Choosing Wisely Africa initiative. She is a co-author in the Lancet Oncology commission for Cancer in Sub-Saharan Africa and is a commissioner in the Lancet Commission on Women, Power and Cancer.
Join us in extending a warm welcome to Dr. Nazik Hammad as she embarks on this exciting journey with ICC!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023